A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants

NCT00322049 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

51

Enrollment

FED

Sponsor class

Conditions

Dengue

Interventions

BIOLOGICAL: Tetravalent live attenuated dengue vaccine
BIOLOGICAL: Varicella vaccine and Haemophilus influenzae Type b Conjugate vaccine

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]